Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

CYC-202 as potential new treatment for lupus nephritis

Nov. 16, 2004

Orphan drug designation for CR-002 in IgA nephropathy

Nov. 15, 2004

Orphan drug status for intravenous terlipressin for type 1 hepatorenal syndrome

Nov. 12, 2004

Acute renal injury in anti-GBM glomerulonephritis acts via a JNK-dependent mechanism

Nov. 11, 2004

Discontinuation of phase II pamirosin trial for BPH

Nov. 11, 2004

Millennium presents new ALK5 inhibitors and their potential applications

Nov. 4, 2004

Preclinical and clinical data support the efficacy of DA-8159 in erectile dysfunction

Oct. 29, 2004

FDA approval for Fosrenol

Oct. 29, 2004

Dapoxetine improves latency time in patients with premature ejaculation

Oct. 28, 2004

European approval for Emselex

Oct. 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...